Outcomes	O

Reductions	B-PrimaryOutcome
of	I-PrimaryOutcome
C	I-PrimaryOutcome
reactive	I-PrimaryOutcome
protein	I-PrimaryOutcome
levels	I-PrimaryOutcome
at	B-TimeFrame
day	I-TimeFrame
5	I-TimeFrame
and	I-TimeFrame
8	I-TimeFrame
after	I-TimeFrame
randomization	I-TimeFrame
were	O
chosen	O
as	O
primary	O
outcome	O
.	O

Secondary	O
outcomes	O
included	O
admission	B-SecondaryOutcome
to	I-SecondaryOutcome
ICU	I-SecondaryOutcome
within	B-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
30	I-TimeFrame
days	I-TimeFrame
from	I-TimeFrame
randomization	I-TimeFrame
,	O
occurrence	B-SecondaryOutcome
of	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
within	B-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
30	I-TimeFrame
days	I-TimeFrame
from	I-TimeFrame
randomization	I-TimeFrame
,	O
death	B-SecondaryOutcome
within	B-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
30	I-TimeFrame
days	I-TimeFrame
from	I-TimeFrame
randomization	I-TimeFrame
,	O
composite	B-SecondaryOutcome
occurrence	I-SecondaryOutcome
of	I-SecondaryOutcome
admission	I-SecondaryOutcome
to	I-SecondaryOutcome
ICU	I-SecondaryOutcome
,	I-SecondaryOutcome
mechanical	I-SecondaryOutcome
ventilation	I-SecondaryOutcome
or	I-SecondaryOutcome
death	I-SecondaryOutcome
within	B-TimeFrame
15	I-TimeFrame
and	I-TimeFrame
30	I-TimeFrame
days	I-TimeFrame
from	I-TimeFrame
randomization	I-TimeFrame
,	O
proportion	B-SecondaryOutcome
of	I-SecondaryOutcome
patients	I-SecondaryOutcome
requiring	I-SecondaryOutcome
supplemental	I-SecondaryOutcome
oxygen	I-SecondaryOutcome
at	B-TimeFrame
day	I-TimeFrame
15	I-TimeFrame
(	O
or	O
with	O
an	O
oxygen	O
saturation	O
lower	O
than	O
96	O
%	O
while	O
breathing	O
room	O
air	O
)	O
,	O
time	B-SecondaryOutcome
from	I-SecondaryOutcome
randomization	I-SecondaryOutcome
to	I-SecondaryOutcome
discharge	I-SecondaryOutcome
up	B-TimeFrame
to	I-TimeFrame
day	I-TimeFrame
15	I-TimeFrame
from	I-TimeFrame
randomization	I-TimeFrame
,	O
and	O
significative	B-SecondaryOutcome
differences	I-SecondaryOutcome
in	I-SecondaryOutcome
serum	I-SecondaryOutcome
lactate	I-SecondaryOutcome
dehydrogenase	I-SecondaryOutcome
levels	I-SecondaryOutcome
at	B-TimeFrame
day	I-TimeFrame
5	I-TimeFrame
and	I-TimeFrame
8	I-TimeFrame
.	O

All	O
the	O
trial	O
outcomes	O
were	O
assessed	O
by	O
the	O
site	O
investigators	O
,	O
who	O
were	O
aware	O
of	O
the	O
trial	O
-	O
group	O
assignments	O
.	O

